Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2016 | 06-2016 | 12-2015 | 06-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,240 | 8,146 | 10,460 | 15,343 | 1,090 |
| Receivables | 540 | 460 | 490 | 598 | 750 |
| Other current assets | 250 | 233 | 490 | 426 | 270 |
| TOTAL | $12,030 | $8,839 | $11,440 | $16,367 | $2,110 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 443 | 480 | 616 | 680 |
| TOTAL | $N/A | $443 | $480 | $616 | $680 |
| Total Assets | $12,340 | $9,683 | $12,390 | $17,332 | $2,950 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 850 | 611 | 440 | 923 | 880 |
| Other current liabilities | 410 | 360 | 380 | 529 | 490 |
| TOTAL | $1,270 | $971 | $830 | $1,451 | $1,380 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | N/A | 0 | 1,280 |
| Other Non-Current Liabilities | 50 | 54 | 50 | 21 | 30 |
| TOTAL | $50 | $54 | $50 | $21 | $1,310 |
| Total Liabilities | $1,320 | $1,025 | $880 | $1,473 | $2,690 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 0 | 83,040 | 0 | 79,820 |
| Retained earnings | -85,080 | -79,741 | -75,880 | -84,474 | -83,010 |
| Other shareholders' equity | 96,100 | 88,399 | 4,340 | 100,333 | 3,440 |
| TOTAL | $11,020 | $8,658 | $11,500 | $15,859 | $250 |
| Total Liabilities And Equity | $12,340 | $9,683 | $12,380 | $17,332 | $2,940 |